Meningitis: Clinical Trials

5 trials for Meningitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 terminated. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Terminated 5

Follow Meningitis: new trials by email Literature Review of Meningitis trials Research Report on Meningitis

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of West Nile Virus With MGAWN1
MGAWN1, Placebo - normal saline - West Nile Neuroinvasive Disease, West Nile Virus Infection
Phase 2TerminatedMacroGenics132009-05-012022-02-10
Study Evaluating Safety, Tolerability, and Immunogenicity of Meningococcal B Vaccine in Healthy Infants
meningococcal B rLP2086 vaccine, Routine age appropriate childhood vaccines - Meningitis, Meningococcal
Phase 2TerminatedPfizer462009-01-012014-11-26
Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS
Mycograb, placebo - Cryptococcal Meningitis
Phase 2TerminatedNovartis Pharmaceuticals32007-03-012008-12-12
Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS
Efungumab (Mycograb), placebo, Amphotericin B - Cryptococcal Meningitis
Phase 2TerminatedNovartis Pharmaceuticals382006-08-012009-02-19
Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy Adults
Meningococcal Polysaccharide Diphtheria Toxoid Conjugate - Meningitis, Meningococcemia
Phase 2TerminatedSanofi Pasteur, a Sanofi Company182004-01-012014-02-14

Narrower conditions

Meningitis, Cryptococcal (2)  ·  Encephalitis (1)  ·  Meningitis, Meningococcal (1)  ·  Meningococcal Infections (1)  ·  West Nile Fever (1)  ·  acute flaccid myelitis (1)

Broader conditions

Infections (5)  ·  Nervous System Diseases (5)  ·  Neuroinflammatory Diseases (5)  ·  Bacterial Infections and Mycoses (4)  ·  Central Nervous System Diseases (4)  ·  Central Nervous System Infections (4)  ·  Bacterial Infections (2)  ·  Central Nervous System Fungal Infections (2)  ·  Cryptococcosis (2)  ·  Gram-Negative Bacterial Infections (2)  ·  Meningitis, Fungal (2)  ·  Mycoses (2)  ·  Neisseriaceae Infections (2)  ·  Arbovirus Infections (1)

Interventions

efungumab (2)  ·  Amphotericin B (1)  ·  Flucytosine (1)  ·  Meningococcal Vaccines (1)

Sponsors

Novartis Pharmaceuticals (2)  ·  MacroGenics (1)  ·  Pfizer (1)  ·  Sanofi Pasteur, a Sanofi Company (1)

Countries

South Africa (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 25077420

NIH funding

2008 (1)